Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Do not use retatrutide if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis Severe gastroparesis or other serious GI motility disorders Known hypersensitivity to any component of the drug Use with caution and close monitoring if you have: Existing cardiovascular disease, given the heart rate increase Gallbladder disease or a history of gallstones Kidney disease, as dehydration from GI side effects can worsen kidney function Type 1 diabetes or insulin-dependent Type 2 diabetes A history of eating disorders, as extreme appetite suppression can interact with disordered eating patterns in unpredictable ways Pregnancy is an absolute contraindication
PT-141 is generally well-tolerated
PubMed, elechowska, P., et al
Check out these helpful links for more:Tirzepatide vs
Pemvidutide not only has meaningful weight loss in addition to the liver effects
These ligands interact with several receptor proteins including AT 1 , AT 2 , AT 4 , and Mas distributed within the central and peripheral nervous systems as well as local RASs in several organs
